This retrospective cohort study evaluates the impact of an AI-supported continuous glucose monitoring (CGM) mobile app (“January V2”) on glycemic control and weight management in 944 users, including healthy individuals and those with prediabetes…
Continue Reading
Researchers at Imperial College London and Imperial College Healthcare NHS Trust have developed an AI tool which could identify people at risk of type 2 diabetes up to 10 years before they begin to…
Continue Reading
Tackling Diabetes Distress in Dual Eligibles Requires Integrated Care ManagementBy Barbara Greising
Barbara Greising, MBA is chief commercial officer at Podimetrics.
Diabetes is a demanding condition. Slipping up even a little can quickly…
Continue Reading
Pharmacotherapy guidelines for type 2 diabetes (T2D) emphasize patient-centered care, but applying this approach effectively in outpatient practice remains challenging. Data-driven treatment optimization approaches could enhance individualized T2D management, but current approaches cannot account…
Continue Reading
Digital phenotyping refers to characterizing human bio-behavior through wearables, personal devices, and digital health technologies. Digital phenotyping in populations facing a disproportionate burden of type 2 diabetes (T2D) and health disparities continues to lag…
Continue Reading
The effectiveness of lifestyle interventions in reducing caloric intake and increasing physical activity for preventing Type 2 Diabetes (T2D) has been previously demonstrated. The use of modern technologies can potentially further improve the success…
Continue Reading
Bayer Digital Healthcare UKI, in collaboration with Cognitant, has launched its first digital patient support package, My Kidney Assistant, designed to provide type 2 diabetes (T2D) patients with the information and resources to help…
Continue Reading
